No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Frontier IP said on Monday that its portfolio company inSignals Neurotech had been awarded a 317,762 grant, co-financed by the EU under Portugal 2030 through the NORTE 2030 programme, to expand its Parkinson's monitoring technology to third-party wearables including smartwatches and smart rings. Frontier IP holds a 32.9% equity stake in the company.
It said InSignals is also launching a mobile app for Parkinson's patients and caregivers, funded by a previous PRR Green Vouchers grant, to support symptom monitoring and communication with clinicians.
Co-founder and chief scientific officer Joo Paulo Cunha said the funding would bring its algorithms "beyond specialised clinical settings and into everyday wearable devices", while Frontier IP chief executive Neil Crabb said the grant and app launch "validate the ground-breaking nature of the Company's technology."
At 1446 BST, shares in Frontier IP Group were up 15.02% at 16.1p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.